The Open House procedure for Rivaroxaban tablet discount contracts, excluding the 2.5 mg strength (ATC B01AF01), will be cancelled effective August 31, 2025. All existing contracts will be terminated on this date, and no new contracts can be concluded under this Open House procedure.
Contract awarded. Originally published 1 years ago.
This is not a standard open procedure but an open-house model! The form for the open procedure is used only because there is no form for the open-house model. Contracts made under the open-house model are not subject to procurement law due to the lack of a selection decision. The AOK Bayern intends
This contract opportunity is for reception and security services required by AOK Bayern - Die Gesundheitskasse. Suppliers are invited to provide professional reception services, which may include managing visitor access, handling inquiries, and ensuring a secure environment. The contract is publishe
This announcement by AOK Bayern aims to provide transparency regarding all contracts concluded under the Open House procedure for pharmaceutical discount contracts according to § 130a Abs. 8 SGB V and § 130a Abs. 8c SGB V from 13.07.2025 to 12.08.2025. AOK Bayern intends to enter into non-exclusive
This is not a standard procurement procedure but an open-house model. The form used is for an open procedure only because there is no specific form for the open-house model. Contracts made under this model are not subject to procurement law due to the lack of a selection decision. AOK Bayern intends
NHS Scotland is seeking suppliers of generic and biosimilar cancer medicines to improve patient access and optimize healthcare costs.
Royal Borough of Greenwich is commissioning a School Health and Wellbeing Service to deliver preventative health and early intervention support for children and young people aged 5-19 years across the borough, with contract commencement in April 2027.
Suffolk County Council is testing market interest for postal delivery of nicotine replacement therapy and smoking cessation medications to improve accessibility for local residents.
PSD Scotland is engaging with the market to explore delivery solutions for a national Targeted Lung Cancer Screening Programme for smokers aged 55-74 in Scotland.
